Updates are available New version dated 2023-10-05

Click to view New version: https://doi.org/10.29328/journal.jcn.1001113

A Case of Catastrophic Atypical Hemolytic Uremic Syndrome Unresponsive to Eculizumab and the use of Ravulizumab Off-label

Crossref DOI link: https://doi.org/10.29328/journal.jcn.1001113

Published Online: 2023-10-05

Published Print: 2023-10-05

Update policy: https://doi.org/10.29328/crossmark-policy

About CrossMark